Abstract:Viruses require host cellular factors for successful replication. A comprehensive systems-level investigation of the virus-host interactome is critical for understanding the roles of host factors with the end goal of discovering new druggable antiviral targets. Gene-trap insertional mutagenesis is a high-throughput forward genetics approach to randomly disrupt (trap) host genes and discover host genes that are essential for viral replication, but not for host cell survival. In this study, we used libraries of randomly mutagenized cells to discover cellular genes that are essential for the replication of 10 distinct cytotoxic mammalian viruses, 1 gram-negative bacterium, and 5 toxins. We herein reported 712 candidate cellular genes, characterizing distinct topological network and evolutionary signatures, and occupying central hubs in the human interactome. Cell cycle phase-specific network analysis showed that host cell cycle programs played critical roles during viral replication (e.g. MYC and TAF4 regulating G0/1 phase). Moreover, the viral perturbation of host cellular networks reflected disease etiology in that host genes (e.g. CTCF, RHOA, and CDKN1B) identified were frequently essential and significantly associated with Mendelian and orphan diseases, or somatic mutations in cancer. Computational drug repositioning framework via incorporating drug-gene signatures from the Connectivity Map into the virus-host interactome identified 110 putative druggable antiviral targets and prioritized several existing drugs (e.g. ajmaline) that may be potential for antiviral indication (e.g. anti-Ebola). In summary, this work provides a powerful methodology with a tight integration of gene-trap insertional mutagenesis testing and systems biology to identify new antiviral targets and drugs for the development of broadly acting and targeted clinical antiviral therapeutics.

There and back again: Discovering antiviral and antiphage defenses using deep homology

Conservation of antiviral systems across domains of life reveals immune genes in humans

Tracing the evolutionary origins of antiviral immunity

Modulation of Host Immune Defenses by Cytomegalovirus: Advanced Insights from Evolutionary Game Theory

Bacterial homologs of innate eukaryotic antiviral defenses with anti-phage activity highlight shared evolutionary roots of viral defenses

Genomic landscape of antiviral defense systems in prokaryotes and phages

Evolutionary immunology to explore original antiviral strategies

Structure-guided discovery of anti-CRISPR and anti-phage defense proteins

New antiviral defences are genetically embedded within prokaryotic immune systems

System-Based Approaches to Delineate the Antiviral Innate Immune Landscape

Conservation and similarity of bacterial and eukaryotic innate immunity

Interpretable machine learning reveals a diverse arsenal of anti-defenses in bacterial viruses

Animal and bacterial viruses share conserved mechanisms of immune evasion

Systematic discovery of antiphage defense systems in the microbial pangenome

An OLD protein teaches us new tricks: prokaryotic antiviral defense

A functional selection reveals previously undetected anti-phage defence systems in the E. coli pangenome

The highly diverse antiphage defence systems of bacteria

The arms race between bacteria and their phage foes

Exploring Viral–Host Protein Interactions as Antiviral Therapies: A Computational Perspective

Biological and bioinformatic tools for the discovery of unknown phage–host combinations

Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis